In a recent historic announcement, the U.S. Drug Enforcement Administration has determined that cannabis, which is currently categorized as a Schedule I drug under the Controlled Substances Act (CSA), should be rescheduled to...more
5/1/2024
/ Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Dispensaries ,
Food and Drug Administration (FDA) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
OMB ,
Schedule I Drugs
In October of 2022, the Biden Administration started an official cannabis policy review process, which began with granting pardons to all people convicted of simple cannabis possession under federal law. At the time, this was...more
9/1/2023
/ Agribusiness ,
Agricultural Sector ,
Business Taxes ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Marijuana ,
Medical Marijuana ,
Medical Research ,
NIDA ,
Pharmaceutical Industry ,
Schedule I Drugs
On Friday, April 1, 2022, the U.S House of representatives voted to pass the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, which decriminalizes cannabis at the federal level. The vote was made mostly along...more
On Monday October 18, 2021, the Drug Enforcement Administration (DEA) issued a notice through the Federal Register that proposed a large increase in production quotas for a number of controlled substances including cannabis...more
Cannabis, or “marihuana” as it is referred to in the Controlled Substances Act (CSA), has been federally illegal in the United States since 1937. Yesterday, Senate Majority Leader Chuck Schumer (D-NY) announced that he will...more
On the heels of the historic vote by the United Nations, which for the first time recognized the medicinal properties of cannabis and removed it from the most restricted substances under the 1961 Convention on Narcotic Drugs,...more
Earlier this week, on November 20th, the House of Representatives judiciary committee approved a bill –The Marijuana Opportunity, Reinvestment, and Expungement Act (“the MORE Act”) – that would legalize cannabis at the...more
Until recently, Illinois’ medical cannabis program was technically a pilot program and it even had an expiration date in 2020. This changed when Gov. J.B. Pritzker signed a new medical cannabis law for Illinois, which will...more
On 5/31, the Illinois House voted to approve the Cannabis Regulation and Tax Act (“CRTA”), which will legalize the sale and use of cannabis for recreational purposes by individuals 21 and older. The State Senate approved the...more
Illinois legislators recently returned from a break and the legalization of cannabis in Illinois appears to be taking center stage. State Rep. Kelly Cassidy, an established cannabis advocate and one of the state’s leaders in...more
While many following the rise of the cannabis industry in the United States have seen CBD-infused food and drink products hitting the market, what many may not know is that CBD-infused products remain illegal at the federal...more
As many following the state of cannabis law in Illinois know, State Rep. Kelly Cassidy and State Sen. Heather Steans have been working on a proposal for the legalization of adult-use recreational cannabis for some time. They...more
Though the government shutdown continues, the new 116th Congress is hard at work and cannabis legislation appears to be a hot topic. In the first three weeks of 2019, three separate cannabis related bills were filed....more
Last night, J.B. Pritzker, the Democratic candidate for Illinois Governor defeated incumbent Republican Bruce Rauner at the polls. Pritzker will be sworn in as governor on January 9, 2019. One of many issues on which the two...more
In June of 2018, in a landmark decision, the FDA issued its first approval of a medicine derived from cannabis, Epidiolex. Manufactured by Britain’s GW Pharmaceuticals, Epidiolex was developed to treat two rare and severe...more
In the same week that Illinois Governor Bruce Rauner signed into law the Alternative to Opioids Act (“AOA”), which allows patients with conditions traditionally treated with opioids to obtain medical cannabis, he signed the...more
On June 25, 2018, for the first time in its history, the Food and Drug Administration approved the use of a drug derived directly from cannabis. The drug, called Epidiolex, treats two specific epileptic syndromes – Dravet...more